HSPA5 and neoplasm: To assess the anti‐proliferative efficacy of GRP78‐targeted PE38, we conducted a CCK8‐based cytotoxicity assay of C5‐PE38 and C9‐PE38 on csGRP78‐expressing tumor cell lines.